Carter's Shoulder Surgery Clears in Fangio's Early Assessment—What It Means for Eagles' Defense This Fall

Jalen Carter missed roughly four weeks of the 2025 regular season following surgical procedures on both shoulders—a compound injury rare enough to trigger league-wide chatter about his durability. Eagles defensive coordinator Vic Fangio offered the first meaningful status update this week, and the signal was unambiguous: Carter is healthy, stronger than before, and ahead of his typical offseason conditioning curve.

That mattering-of-fact clearance from a trusted defensive mind carries weight, but it also masks a structural question the market will eventually price. Carter's 2027 fifth-year option sits at $27.1 million, and the Eagles have already signaled openness to moving him by exploring trade calls in March after signing Jordan Davis to a $26 million-per-year extension. The team's simultaneous investment in Davis and willingness to shop Carter suggests they view the two as closer in value than the contract numbers suggest—a valuation gap that usually presages movement. Fangio's optimism, however, may temporarily suppress that conversation and keep Carter's injury discount artificially baked into team defense projections for the early part of the 2026 season.

From a defensive prop standpoint, Carter's early return to heavy lifting and Fangio's stamp of approval should elevate his tackle and sack expectations relative to preseason projections. Carter finished 2025 with 5.5 sacks in 12 games before the shutdown—a 7.3-sack annualized pace in a truncated sample. If the Eagles view him as fully healthy entering Year 4, and if he reclaims his pre-injury workload without ramp-down weeks, his tackle volume (he averaged 4.2 per game in 2025 before the injury) and sack opportunity should both climb. Books pricing him based on injury-weighted snap counts from March will likely overcorrect downward; Fangio's explicit health confirmation creates a window before consensus line adjustments catch up.

The durability risk, however, has not disappeared—it has only been reframed. Bilateral shoulder surgery is a signal that the underlying joint mechanics required intervention. Early strength gains and optimistic coach commentary are necessary but insufficient evidence that re-injury risk has normalized to his pre-injury baseline. Any Jalen Carter tackle or sack prop that opened at a discount to his 2024 performance should track as a value play only through Week 2; by Week 3, if he logs 40+ snaps without incident, the market will have repriced the injury cost entirely. The edge is temporal, not durable.